Abstract

Worldwide, retinal deficiency of prematurity, or (ROP), continues to be a major cause of blindness and visual impairment in preterm infants. Control efforts face substantial obstacles as the frequency of ROP and its associated visual impairment continue to rise in some locations despite breakthroughs in newborn child care. The objective of this article is to present a summary of the current understanding of ROP, including risk factors, screening recommendations, pathophysiology, and therapy approaches. Premature children, especially those delivered before 32 weeks of pregnancy or weighing less than 1500 grammes at birth, are more susceptible to ROP because of aberrant retinal vascular development in these cases. ROP is influenced by a number of risk factors, which can include low birth weight, prolonged oxygen therapy, and systemic disorders. For the proper early detection and treatment of ROP, timely screening with retinal examination is essential. Surgical intervention in severe cases, anti-vascular endothelial growth factor (anti-VEGF) injections, laser therapy, and observation are among the management techniques for ROP. The results for newborns with ROP have improved thanks to developments in ophthalmology and neonatal care; yet, issues like longterm follow-up and access to care still need to be resolved.

• 1.   Bhende, P. (2020). Retinopathy of prematurity. Indian Journal of Ophthalmology, 68(13), 10. https://doi. org/10. 4103/ijo. ijo_2378_19
• 2.   Chiang, M. F., Quinn, G. E., Fielder, A. R., Ostmo, S. R., Paul Chan, R. V., Berrocal, A., Binenbaum, G., Blair, M., Peter Campbell, J., Capone, A., Chen, Y., Dai, S., Ells, A., Fleck, B. W., Good, W. V., Elizabeth Hartnett, M., Holmstrom, G., Kusaka, S., Kychenthal, A., & Lepore, D. (2021). International Classification of Retinopathy of Prematurity, Third Edition. Ophthalmology, 128(10), e51–e68. https://doi. org/10. 1016/j. ophtha. 2021. 05. 031
• 3.   Gupte, S. (2016). The short Textbook of Pediatrics (12th edition, pp. 804–805). Jaypee Brothers Medical Publishers (P) Ltd.
• 4.   Hong, E. H., Shin, Y. U., & Cho, H. (2022). Retinopathy of prematurity: a review of epidemiology and current treatment strategies. Clinical and Experimental Pediatrics, 65(3), 115– 126. https://doi. org/10. 3345/cep. 2021. 00773
• 5.   Kim, S. J., Port, A. D., Swan, R., Campbell, J. P., Chan, R. V. P., & Chiang, M. F. (2018). Retinopathy of prematurity: a review of risk factors and their clinical significance. Survey of Ophthalmology, 63(5), 618–637. https://doi. org/10. 1016/j. survophthal. 2018. 04. 002
• 6.   Paul, vinod K., & Bagga, A. (2013). Ghae essential Pediatrics (Eighth, pp. 666–667). CBS Publishers. (Original work published 2013)
• 7.   Sabri, K., Ells, A. L., Lee, E. Y., Dutta, S., &Vinekar, A. (2022). Retinopathy of Prematurity: A Global Perspective and Recent Developments. Pediatrics, 150(3). https://doi. org/10. 1542/peds. 2021-053924
• 8.   Sam Ebenezer Athikarisamy, Anand Vinekar, & Sanjay Patole. (2023). Retinopathy of prematurity in India – what can we learn from the polio legacy? The Lancet Regional Health - Europe, 14, 100210–100210. https://doi. org/10. 1016/j. lansea. 2023. 100210
• 9.   Tsai, A. S. H., Acaba-Berrocal, L., Sobhy, M., Cole, E., Ostmo, S., Jonas, K., Campbell, J. P., Chiang, M. F., & Chan, R. V. P. (2022). Current Management of Retinopathy of Prematurity. Current Treatment Options in Pediatrics, 8(3), 246–261. https://doi. org/10. 1007/s40746- 022-00249-8

Data Sharing Statement

Funding